無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

消化酵素の世界市場 - 成長、動向、予測(2018年〜2023年)

Global Digestive Enzymes Market - Segmented By Enzyme Type (Carbohydrase, Protease, Lipase, and Other Types), By Application, By Origin, and By Geography- Growth, Trends, and Forecast (2018 - 2023)

発行 Mordor Intelligence LLP 商品コード 708648
出版日 ページ情報 英文 110 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.79円で換算しております。
Back to Top
消化酵素の世界市場 - 成長、動向、予測(2018年〜2023年) Global Digestive Enzymes Market - Segmented By Enzyme Type (Carbohydrase, Protease, Lipase, and Other Types), By Application, By Origin, and By Geography- Growth, Trends, and Forecast (2018 - 2023)
出版日: 2018年09月01日 ページ情報: 英文 110 Pages
概要

当レポートでは、消化酵素の世界市場を調査し、市場の概要、タイプ、用途、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替製品とサービスの脅威
    • 業界内での競争

第6章 市場ダイナミクス

  • 成長要因
  • 阻害要因
  • 市場機会
  • 課題

第7章 市場セグメンテーション

  • 酵素タイプ別
    • カルボヒドラーゼ
    • プロテアーゼ
    • リパーゼ
    • その他
  • 用途別
    • 幼児栄養
    • 医療栄養
    • スポーツ栄養
    • その他
  • 原産別
    • 動物
    • 真菌
    • 微生物
    • 植物
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第8章 企業プロファイル

  • AbbVie Inc.
  • Allergan PLC
  • Amano Enzyme Inc.
  • Amway Corporation
  • Biotics Research Corporation
  • Country Life LLC
  • Garden of Life Inc.
  • National Enzyme Company Inc.
  • Johnson & Johnson Inc.

第9章 市場の将来展望

目次
Product Code: 64282

The Digestive Enzymes Market is expected to grow at a CAGR of 7.2% over the forecast period.

Digestive enzymes represent a group of enzymes secreted by digestive organs for breaking down complex macromolecules into their constituents, in order to facilitate their absorption by the body. Several digestive enzymes are commercially available as dietary supplements and for the management of digestive disorders. Factors such as rising geriatric population, rising prevalence of gastrointestinal disorders, increasing awareness about GI health, and focus on preventive health management are contributing to the market growth. However, the general public's perception of probiotic and prebiotic products as alternatives to digestive enzymes and stringent regulatory policies could adversely affect the growth of the market.

Rising Geriatric Population and Age-associated GI Disorders are Contributing to Market Growth

The global population is aging rapidly, owing to reduced birth rates and increasing life expectancy. The demographic trend towards an aging population represents a growing need for the management of disorders such as GI tract obstructions. The number of older people is estimated to increase by nearly 60% in the next 15 years, and by 2030, the total number of people above age 65 is expected to be more than a billion, i.e., the geriatric population would represent 12% of the global population. By 2050, this number is expected to cross 1.6 billion, or 16.7% of total population. The secretion of digestive enzymes usually decreases with age, which contributes to high levels of gastric discomfort, lower digestion rates, reduced food consumption, and/or a variety of other GI disorders.

Other factors that are contributing to market growth include the rising prevalence of gastrointestinal disorders, increasing awareness about GI health, and focus on preventive health management.

Perception of Probiotic and Prebiotic Products as Alternatives to Digestive Enzymes is Limiting the Growth of the Market

Probiotic and digestive enzyme supplements are complementary products that can work together to support optimal digestive health. In recent years, owing to increased consumer focus on healthy living and preventive care there has been a growing trend of using probiotics and prebiotics for maintaining general GI health. However, probiotic/prebiotic products and digestive enzymes are often marketed to help in the management of similar digestive issues, when, in fact, they perform a totally different function. This improper marketing has created a perception in the general public that probiotic and prebiotic products can be used as an alternative to digestive enzymes.

Other factors that could potentially impede market growth include stringent regulatory policies.

North America Dominates the Digestive Enzymes Market

In 2017, North America was the largest regional market, in terms of revenue. The increasing prevalence of chronic gastrointestinal diseases, rapidly aging population, growing demand for preventive medicine, and the presence of major market players are primary factors contributing to large market size. Apart from the high prevalence of GI disorders, changing lifestyle, unhealthy eating habits, and high disposable income is contributing to high growth rates.

Key Developments in the Digestive Enzymes Market:

  • Jul 2017: Alcresta Therapeutics received 510(K) clearance for the use of RELiZORB® in children.
  • Major Players: AbbVie Inc., Allergan PLC, Amano Enzyme Inc., Amway Corporation, Biotics Research Corporation, Country Life LLC, Garden of Life Inc., National Enzyme Company Inc., and Johnson & Johnson Inc., among others

Reasons to Purchase Digestive Enzymes Market Report:

  • Analysis of various perspectives of the global digestive enzyme market, with the help of Porter's five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identification of the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Digestive Enzymes Market Report:

This report can be customized to meet your requirements. Please connect with our representative, who will ensure that you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1. Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1. Current Market Scenario
  • 5.2. Porter's Five Forces Analysis
    • 5.2.1. Bargaining Power of Suppliers
    • 5.2.2. Bargaining Power of Consumers
    • 5.2.3. Threat of New Entrants
    • 5.2.4. Threat of Substitute Product and Services
    • 5.2.5. Competitive Rivalry within the Industry

6. Market Dynamics

  • 6.1. Drivers
    • 6.1.1. Rising Geriatric Population
    • 6.1.2. Rising Prevalence of Gastrointestinal Disorders
    • 6.1.3. Increasing Awareness about GI Health and Focus on Preventive Health Management
  • 6.2. Restraints
    • 6.2.1. Perception of Probiotic and Prebiotic Products as Alternatives to Digestive Enzymes
    • 6.2.2. Stringent Regulatory Policies
  • 6.3. Opportunities
  • 6.4. Challenges

7. Market Segmentation

  • 7.1. By Enzyme Type
    • 7.1.1. Carbohydrase
    • 7.1.2. Protease
    • 7.1.3. Lipase
    • 7.1.4. Other Enzyme Types
  • 7.2. By Application
    • 7.2.1. Infant Nutrition
    • 7.2.2. Medical Nutrition
    • 7.2.3. Sports Nutrition
    • 7.2.4. Other Applications
  • 7.3. By Origin
    • 7.3.1. Animal
    • 7.3.2. Fungi
    • 7.3.3. Microbial
    • 7.3.4. Plant
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States
      • 7.4.1.2. Canada
      • 7.4.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. France
      • 7.4.2.2. Germany
      • 7.4.2.3. United Kingdom
      • 7.4.2.4. Italy
      • 7.4.2.5. Spain
      • 7.4.2.6. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China
      • 7.4.3.2. Japan
      • 7.4.3.3. India
      • 7.4.3.4. Australia
      • 7.4.3.5. South Korea
      • 7.4.3.6. Rest of Asia-Pacific
    • 7.4.4. Middle East & Africa
      • 7.4.4.1. GCC
      • 7.4.4.2. South Africa
      • 7.4.4.3. Rest of the Middle East & Africa
    • 7.4.5. South America
      • 7.4.5.1. Brazil
      • 7.4.5.2. Argentina
      • 7.4.5.3. Rest of South America

8. Company Profiles and Competitive Landscape

  • 8.1. AbbVie Inc.
  • 8.2. Allergan PLC
  • 8.3. Amano Enzyme Inc.
  • 8.4. Amway Corporation
  • 8.5. Biotics Research Corporation
  • 8.6. Country Life LLC
  • 8.7. Garden of Life Inc.
  • 8.8. National Enzyme Company Inc.
  • 8.9. Johnson & Johnson Inc.

List Not Exhaustive

9. Future of the Market

Back to Top